We specialize in siRNA drug discovery and development. Our industry-leading siRNA platform technology, RADS™ (RNA molecules with superior Activity, Durability, and Safety), is the cornerstone of our innovation. Built on this platform, our therapies are designed with the potential to deliver meaningful impact, with the goal of just one injection per year in clinical practice for certain indications.